Jan 2, 2019

2019's drug price hikes are here

Drug price increases are here again. Photo: Gerard Julien/AFP/Getty Images

A handful of pharmaceutical companies raised the prices of their drugs, effective Jan. 1, according to the Wall Street Journal and reports from pharmaceutical industry analysts.

The bottom line: This was expected, and the drug price increases will continue. Drug companies are following through on decisions that prioritize earnings over politics.

Details: New Year's Day traditionally has been a popular time for drugmakers to hike prices. This story from last January is almost identical to what is playing out again this year. Here are some of the increases in list prices, which do not include rebates:

  • AbbVie: Humira, a blockbuster drug with $15 billion in sales in the first 9 months of 2018 — ⬆️ 6.2%
  • Allergan: Many of its brand-name drugs, including dry-eye medication Restasis — ⬆️ 9.5%
  • Biogen: Multiple sclerosis drug Tecfidera — ⬆️ 6%
  • Bristol-Myers Squibb: Eliquis, a drug that prevents blood clots and is on pace for $6 billion in sales in 2018 — ⬆️ 6%
  • Eli Lilly: Type 2 diabetes medication Jardiance — ⬆️ 6%
  • Hikma Pharmaceuticals: Injectable pain reliever morphine — ⬆️ 10%
  • Teva: Similar to Allergan, many of its products — ⬆️ 9%

Looking ahead: "Some companies chose to go forward early, but by the end of January, we expect the majority to raise," said Ronny Gal, a pharmaceutical industry analyst at Bernstein.

Go deeper: The drug pricing maze

Go deeper

The coronavirus is Trump's slow-burn crisis

Photo: Money Sharma/AFP/Getty Images

At 6:30 p.m. from the White House press room, President Trump will publicly make himself the face of America's response to the coronavirus crisis.

Why it matters: This is exactly the situation where a president needs the credibility to truthfully explain a tough situation to the public.

Obama demands South Carolina stations stop airing misleading anti-Biden ad

Photo: Samir Hussein/Samir Hussein/WireImage

Former President Obama's office is calling on South Carolina TV stations to stop running a misleading attack ad by a pro-Trump super PAC that uses Obama's voice out of context to make it appear as if he is criticizing Joe Biden and Democrats on race.

Why it matters: It's a rare intervention by Obama, whose former vice president is facing a critical primary in South Carolina on Saturday. Obama has said he has no plans to endorse in the Democratic field.

The megatrends that will shape the 21st century

Illustration: Eniola Odetunde/Axios

An enormous amount of change has been crammed into the first two decades of the 21st century — but what’s coming next will break every speed record.

The big picture: The world is being buffeted by rapid yet uneven advances in technology that will revamp work and what it means to be human. At the same time, fundamental demographic changes will alter democracies and autocracies alike while the effects of climate change accumulate, physically redrawing our globe.